3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Conditions
Precancerous Conditions
1
Interventions
Biopsy
8
Polymerase Chain Reaction
6
Peripheral Blood Stem Cell Transplantation
5
Epoetin Alfa
5
Sulindac
4
Microarray Analysis
4
Gene Expression Profiling
4
Cyclophosphamide
4
Colposcopy
4
Cetuximab
4
Celecoxib
4
fludarabine phosphate
3
Vaginal Smears
3
Selenium
3
Methotrexate
3
Imiquimod
3
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
3
Eflornithine
3
Darbepoetin alfa
3
Aspirin
3
Antilymphocyte Serum
3
Whole-Body Irradiation
2
Vitamin E
2
Tacrolimus
2
Radiotherapy, Intensity-Modulated
2
Methylprednisolone
2
Light Coagulation
2
Interferon-alpha
2
In Situ Hybridization, Fluorescence
2
Immunohistochemistry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Precancerous Conditions
×
artemisinin
×
Clear all
NCT03100045
2021-11-03
ART-AIN
Johns Hopkins University
Phase 1
Completed
18 enrolled